Quantcast
Channel: ClinicalTrials.gov: Active, not recruiting, Completed, Enrolling by invitation, Suspended, Terminated, Withdrawn, No longer available, Temporarily not available, Approved for marketing, Unknown status Studies
Viewing all 28373 articles
Browse latest View live

Alefacept in Patients With Severe Scalp Alopecia Areata

0
0
Condition:   Alopecia Areata
Intervention:   Drug: Alefacept
Sponsors:   University of Minnesota - Clinical and Translational Science Institute;   National Alopecia Areata Foundation
Completed - verified February 2013

Thalidomide in Combination With Capecitabine in Patients With Metastatic Breast Cancer

0
0
Condition:   Breast Cancer
Interventions:   Drug: Thalidomide;   Drug: Capecitabine
Sponsors:   SCRI Development Innovations, LLC;   Celgene Corporation
Terminated - verified May 2011

Cancer and Osteoporosis Research With Alendronate and Lupron (C.O.R.A.L )

0
0
Condition:   Osteoporosis
Intervention:   Drug: Alendronate
Sponsors:   Canadian Urology Research Consortium;   Abbott;   Merck Frosst Canada Ltd.
Terminated - verified August 2009

Study of the Safety and Immune Response of a Meningococcal Vaccine Administered to Healthy Infants

0
0
Condition:   Prevention of Meningococcal Disease
Interventions:   Biological: MenACWY Ad- (MenACWY-CRM, non adjuvanted formulation);   Biological: MenACWY Ad+ (MenACWY-CRM, adjuvanted formulation);   Biological: MenACWY PS (MenACWY-CRM, polysaccharide vaccine);   Biological: HBV (Hepatitis B vaccine);   Biological: Prevnar (pneumococcal polysaccharide serotypes 4, 9V, 14, 18C, 19F, 23F & 6B conjugated to the CRM197);   Biological: MMR (Measles, Mumps and Rubella vaccine);   Biological: DTaPHibIPV (Diphtheria, Tetanus, acellular Pertussis, H. Influenzae type b, Inactivated Poliovaccine);   Biological: Menjugate (Men C conjugated vaccine)
Sponsors:   Novartis Vaccines;   Novartis
Completed - verified June 2014

Comparison of Penetrating Keratoplasty and Deep Lamellar Keratoplasty With the Big Bubble Technique for Keratoconus

0
0
Condition:   Keratoconus
Intervention:   Procedure: keratoplasty
Sponsor:   Shahid Beheshti Medical University
Active, not recruiting - verified January 2007

Effects of Growth Hormone on the Nitric Oxide Pathway

0
0
Condition:   Cardiovascular Disease
Intervention:   Drug: Somatropin
Sponsors:   Hannover Medical School;   Pharmacia
Completed - verified May 2007

Phenotype Evaluation in Insulin Naive Patients Using Lantus (Insulin Glargine)

0
0
Condition:   Type 2 Diabetes
Intervention:   Drug: Lantus (insulin glargine) + Glucophage (Metformin)
Sponsor:   Sanofi
Completed - verified December 2008

A Multicenter Randomized Trial Comparing Antiglide and Lateral Plate Fixation in Ankle Fractures

0
0
Condition:   Ankle Injuries
Interventions:   Device: Antiglide Plate;   Device: Lateral Plate
Sponsor:   Boston Medical Center
Completed - verified March 2013

Radiosurgical Treatment for Obsessive-compulsive Disorder

0
0
Condition:   Obsessive-compulsive Disorder
Intervention:   Procedure: ventral capsular/ventral striatal gamma capsulotomy
Sponsors:   University of Sao Paulo General Hospital;   Brown University
Terminated - verified October 2012

A Study With RO5095932 in Patients With Type 2 Diabetes on Stable Metformin Therapy.

0
0
Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Placebo;   Drug: Placebo;   Drug: RO5095932;   Drug: RO5095932
Sponsor:   Hoffmann-La Roche
Completed - verified March 2015

BAY12-8039, iv/Oral Pulmonary Abscess/Aspiration Pneumonia

0
0
Conditions:   Pneumonia, Aspiration;   Lung Abscess
Interventions:   Drug: Avelox (Moxifloxacin, BAY12-8039);   Drug: Sulbactam/Ampicillin
Sponsor:   Bayer
Completed - verified January 2010

A Phase 3 Study of Brentuximab Vedotin (SGN-35) in Patients at High Risk of Residual Hodgkin Lymphoma Following Stem Cell Transplant (The AETHERA Trial)

0
0
Condition:   Disease, Hodgkin
Interventions:   Drug: brentuximab vedotin;   Drug: placebo
Sponsors:   Seattle Genetics, Inc.;   Millennium Pharmaceuticals, Inc.
Active, not recruiting - verified March 2015

Effectiveness of a Hand-held Fan for Breathlessness

0
0
Conditions:   Primary Lung Cancer or Secondary Lung Metastases;   COPD III/IV
Interventions:   Device: hand-held fan;   Device: wristband
Sponsor:   King's College London
Completed - verified July 2006

Lidocaine and Outpatient Gynecologic Laparoscopy

0
0
Condition:   Pain
Interventions:   Drug: Placebo;   Drug: Lidocaine
Sponsor:   Northwestern University
Completed - verified June 2014

Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer

0
0
Conditions:   Stage III Ovarian Epithelial Cancer;   Stage III Ovarian Germ Cell Tumor;   Stage IV Ovarian Epithelial Cancer;   Stage IV Ovarian Germ Cell Tumor
Interventions:   Biological: pUMVC3-hIGFBP-2 multi-epitope plasmid DNA vaccine;   Other: laboratory biomarker analysis
Sponsors:   University of Washington;   National Cancer Institute (NCI)
Active, not recruiting - verified June 2014

Effect of Multiple Dosing With BI 201335 on the Pharmacokinetics of Darunavir Co-administered With Ritonavir in Healthy Male and Female Volunteers

0
0
Condition:   HIV Infections
Interventions:   Drug: Darunavir;   Drug: Ritonavir;   Drug: BI 201335
Sponsor:   Boehringer Ingelheim
Completed - verified October 2013

Safety and Immunological Effects of Two Mistletoe Preparations in Healthy Volunteers

0
0
Condition:   Healthy Volunteers
Intervention:   Drug: mistletoe preparations
Sponsor:   University Hospital Freiburg
Completed - verified May 2007

CT-011 and p53 Genetic Vaccine for Advanced Solid Tumors

0
0
Conditions:   Breast Cancer;   Colon Cancer;   Pancreatic Cancer;   Sarcoma;   Ovarian Cancer
Interventions:   Biological: p53: 264-272 peptide;   Drug: CT-011
Sponsor:   National Cancer Institute (NCI)
Withdrawn - verified October 2011

Sensitivity of Short and Long Allele Carriers of the 5-HTTLPR to Environmental Threat Post Hydrocortisone Administration

0
0
Conditions:   Major Depressive Disorder;   Anxiety Disorders
Intervention:   Drug: Hydrocortisone
Sponsor:   University of Texas at Austin
Completed - verified August 2013

A Randomised, Parallel-group, Double-blind, Double-dummy Study to Compare the Effects of Lacidipine Versus Bendrofluazide on Markers of Platelet Activation and Haemorheological Factors in Hypertensive Patients

0
0
Condition:   Hypertension
Interventions:   Drug: Lacidipine;   Drug: Bendrofluazide;   Drug: Placebo
Sponsor:   Boehringer Ingelheim
Completed - verified September 2014
Viewing all 28373 articles
Browse latest View live




Latest Images